One interesting finding is that there are five compounds to which TP53-mutated cancer cell lines are more sensitive than TP53-wildtype cancer cell lines, whereas there are many more (73) compounds to which TP53-wildtype cancer cell lines are more sensitive than TP53-mutated cancer cell lines (Supplementary Table S21). Here, TP53 is linked to cancer.